Glimepiride Supplier-Buyer Network — Trade Flow Analysis

Name: Glimepiride Supplier-Buyer Trade Network Dataset — 242+ Indian Exporters, 14+ Importers, 94+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Glimepiride supplier network, Glimepiride buyers, pharmaceutical export India, Glimepiride trade data

TransData Nexus

Glimepiride

India Pharmaceutical Trade Intelligence

$76.3M242 Suppliers94 CountriesHS 30049099

ExportsIndia → UNITED STATES67.1%India → SOUTH AFRICA4.8%

ImportsMALTA → India$43.6K GREECE → India$5.3K

#1 Supplier: INDOCO REMEDIES #1 Buyer: EVERSANA LIFE

Who Supplies Glimepiride? Top Manufacturers & Buyers 2026 — INDOCO REMEDIES LIMITED Leads | TransData Nexus | TransData Nexus

1INDOCO REMEDIES LIMITED

INDOCO REMEDIES LIMITED is the first-largest Glimepiride exporter from India, with a market share of 60.4% and a total export value of $46.0M across 41 shipments. Their average shipment value of $1.1M is above the market average of $24.2K, suggesting premium or bulk contract pricing.

INDOCO REMEDIES LIMITED serves 1 named buyer in our database. NA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• NA — $46.0M across 41 shipments (100.0% of this supplier's total exports)

Key Insight: INDOCO REMEDIES LIMITED's per-shipment value of $1.1M is 4550% above the market average of $24.2K, consistent with large-order contracts or value-added formulations.

2IPCA LABORATORIES LIMITED

IPCA LABORATORIES LIMITED is the second-largest Glimepiride exporter from India, with a market share of 4.2% and a total export value of $3.2M across 90 shipments. Their average shipment value of $36.0K is above the market average of $24.2K, suggesting premium or bulk contract pricing.

IPCA LABORATORIES LIMITED serves 5 named buyers in our database. NA is the dominant customer, accounting for 84.3% of this supplier's tracked business. Top customers include:

• NA — $2.7M across 76 shipments (84.3% of this supplier's total exports)

• MSJ LIMITED (UNICORN — $201.2K across 6 shipments (6.2% of this supplier's total exports)

• R.A. WILLIAMS DISTRI — $148.6K across 4 shipments (4.6% of this supplier's total exports)

• R A WILLIAMS DISTRIB — $89.4K across 2 shipments (2.8% of this supplier's total exports)

• MASSY DISTRIBUTION ( — $70.9K across 2 shipments (2.2% of this supplier's total exports)

Key Insight: IPCA LABORATORIES LIMITED's per-shipment value of $36.0K is 49% above the market average of $24.2K, consistent with large-order contracts or value-added formulations.

3MICRO LABS LIMITED

MICRO LABS LIMITED is the third-largest Glimepiride exporter from India, with a market share of 4.0% and a total export value of $3.1M across 439 shipments. Their average shipment value of $7.0K is below the market average of $24.2K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES LLC — $939.5K across 135 shipments (30.7% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES — $704.6K across 101 shipments (23.0% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES LLC — $672.5K across 97 shipments (22.0% of this supplier's total exports)

• BROWN AND BURK PHILIPPINES INC — $428.9K across 62 shipments (14.0% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES LLC — $312.0K across 45 shipments (10.2% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (439 shipments) at a per-shipment value of $7.0K, indicating a broad distribution network with many smaller, regular orders.

4MEDREICH LIMITED

MEDREICH LIMITED is the fourth-largest Glimepiride exporter from India, with a market share of 2.3% and a total export value of $1.8M across 42 shipments. Their average shipment value of $42.6K is above the market average of $24.2K, suggesting premium or bulk contract pricing.

MEDREICH LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MEIJI SEIKA PHARMATECH CO LIMITED — $818.7K across 19 shipments (45.7% of this supplier's total exports)

• MEIJI SEIKA PHARMATECH CO LIMITED — $629.2K across 15 shipments (35.1% of this supplier's total exports)

• MEIJI SEIKA PHARMATECH CO LIMITED — $170.6K across 4 shipments (9.5% of this supplier's total exports)

• MEIJI SEIKA PHARMATECH CO LIMITED — $110.6K across 3 shipments (6.2% of this supplier's total exports)

• MEIJI SEIKA PHARMA C — $61.4K across 1 shipments (3.4% of this supplier's total exports)

Key Insight: MEDREICH LIMITED's per-shipment value of $42.6K is 77% above the market average of $24.2K, consistent with large-order contracts or value-added formulations.

5INVENTIA HEALTHCARE LIMITED

INVENTIA HEALTHCARE LIMITED is the fifth-largest Glimepiride exporter from India, with a market share of 2.1% and a total export value of $1.6M across 108 shipments. Their average shipment value of $14.6K is below the market average of $24.2K, reflecting a high-volume, competitive pricing strategy.

INVENTIA HEALTHCARE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MAXXCARE COMPANY LIMITED. — $476.0K across 33 shipments (30.3% of this supplier's total exports)

• MAXXCARE COMPANY LIMITED. — $405.9K across 28 shipments (25.8% of this supplier's total exports)

• I.E. MEDICA INC. — $261.1K across 18 shipments (16.6% of this supplier's total exports)

• HEALOL PHARMACEUTICALS SDN. BHD., — $218.4K across 15 shipments (13.9% of this supplier's total exports)

• I.E. MEDICA INC. — $211.0K across 14 shipments (13.4% of this supplier's total exports)

Key Insight: INVENTIA HEALTHCARE LIMITED operates with high shipment frequency (108 shipments) at a per-shipment value of $14.6K, indicating a broad distribution network with many smaller, regular orders.

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Glimepiride exporter from India, with a market share of 1.2% and a total export value of $908.8K across 66 shipments. Their average shipment value of $13.8K is below the market average of $24.2K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• I AND M BANK (T) LTD — $247.5K across 18 shipments (27.2% of this supplier's total exports)

• MYIT MAHAR TRADING C — $239.1K across 17 shipments (26.3% of this supplier's total exports)

• NA — $196.1K across 14 shipments (21.6% of this supplier's total exports)

• MYIT MAHAR TRADING C — $144.7K across 11 shipments (15.9% of this supplier's total exports)

• TO THE ORDER OF NATI — $81.4K across 6 shipments (9.0% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (66 shipments) at a per-shipment value of $13.8K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Glimepiride imports from India, with a total trade value of $51.2M across 122 shipments — representing a 67.1% share of all Glimepiride exports. The average shipment value of $419.7K is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.

Named Glimepiride importers in United States: EVERSANA LIFE SCIENCE SERVICES, LLC is the largest buyer, accounting for 2.5% ($1.3M) of this market's total imports.

• EVERSANA LIFE SCIENCE SERVICES, LLC — $1.3M (2.5% of United States's total)

• EVERSANA LIFE SCIENCE SERVICES LLC — $905.2K (1.8% of United States's total)

• AMERISOURCE HEALTH SERVICES — $704.6K (1.4% of United States's total)

Key Insight: United States's per-shipment average of $419.7K (1638% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Glimepiride imports from India.

Primary Market

Secondary Market

2South Africa

South Africa ranks as the second-largest destination for Glimepiride imports from India, with a total trade value of $3.7M across 0 shipments — representing a 4.8% share of all Glimepiride exports. The average shipment value of $3.7M is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: South Africa's per-shipment average of $3.7M (15051% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Glimepiride imports from India.

Primary Market

Secondary Market

3Philippines

Philippines ranks as the third-largest destination for Glimepiride imports from India, with a total trade value of $3.4M across 68 shipments — representing a 4.5% share of all Glimepiride exports. The average shipment value of $50.1K is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Glimepiride importers in Philippines: AJANTA PHARMA PHILIPPINES INC is the largest buyer, accounting for 23.3% ($795.0K) of this market's total imports.

• AJANTA PHARMA PHILIPPINES INC — $795.0K (23.3% of Philippines's total)

• I.E. MEDICA INC. — $574.6K (16.9% of Philippines's total)

• BROWN AND BURK PHILIPPINES INC — $460.0K (13.5% of Philippines's total)

Key Insight: Philippines's per-shipment average of $50.1K (108% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Glimepiride imports from India.

Primary Market

Secondary Market

4Japan

Japan ranks as the fourth-largest destination for Glimepiride imports from India, with a total trade value of $2.3M across 28 shipments — representing a 3.0% share of all Glimepiride exports. The average shipment value of $81.5K is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Glimepiride importers in Japan: MEIJI SEIKA PHARMATECH CO., LTD is the largest buyer, accounting for 36.8% ($840.5K) of this market's total imports.

• MEIJI SEIKA PHARMATECH CO., LTD — $840.5K (36.8% of Japan's total)

• MEIJI SEIKA PHARMATECH CO LIMITED — $818.7K (35.9% of Japan's total)

Key Insight: Japan's per-shipment average of $81.5K (238% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Japan is a key market for Glimepiride imports from India.

Primary Market

Secondary Market

5Cyprus

Cyprus ranks as the fifth-largest destination for Glimepiride imports from India, with a total trade value of $1.4M across 0 shipments — representing a 1.8% share of all Glimepiride exports. The average shipment value of $1.4M is above the global average of $24.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: Cyprus's per-shipment average of $1.4M (5731% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Cyprus is a key market for Glimepiride imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Glimepiride.
2.Flow Mapping: 242 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,159 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 94 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,159 Verified Shipments

242 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Glimepiride

Glimepiride

Who Supplies Glimepiride? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Glimepiride — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Glimepiride? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Glimepiride Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1INDOCO REMEDIES LIMITED

2IPCA LABORATORIES LIMITED

3MICRO LABS LIMITED

4MEDREICH LIMITED

5INVENTIA HEALTHCARE LIMITED

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

From Indian Factories to Global Pharmacies — How Glimepiride Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Glimepiride Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2South Africa

3Philippines

4Japan

5Cyprus

People Also Ask — Glimepiride Supplier & Trade Network

Glimepiride Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology